Posted on January 28, 2013
UBC’s Centre for Applied Neurogenetics, within the Faculty of Medicine, Division of Neurology and Department of Medical Genetics at the University of British Columbia, seeks a Postdoctoral Fellow/Research scientist to help define the genetic etiology of neurologic and neurodegenerative disease.
Current studies focus on the identification and validation of novel genetic factors involved in Parkinson’s disease through classical linkage, GWAS and next-generation sequencing (Farrer M. Nat. Rev. Genet. 2006; Farrer M. et al., Nat. Genet. 2008; Vilarino-Guell C. et al., Am. J. Hum. Genet. 2011). Results are used for diagnostic and therapeutic development in partnership with other academic groups and the Pharmaceutical industry (Lewis J. et al., Mol. Neurodegeneration 2008; Melrose H et al., Neurobio Dis. 2010).
The successful candidate will hold a Ph.D. specializing in human molecular genetics, with an aptitude for molecular biology, statistical genetics and/or bioinformatics. He/she will have demonstrated research acumen and have a track record of successful publications, ideally in neurologic and/or neurodegenerative disease.
For its beauty and amenities Vancouver is consistently ranked within the top 5 cities to live in the world. The University of British Columbia is ranked 22nd in Life Science, in which neuroscience is strength. The successful applicant would become part of an expanding program at the cutting edge of applied research for brain disorders.
Please submit your CV and 3 written references to jobs@can.ubc.ca as soon as possible.
UBC hires on the basis of merit and is committed to employment equity. All qualified persons are encouraged to apply. UBC is strongly committed to diversity within its community and especially welcomes applications from visible minority group members, women, Aboriginal persons, persons with disabilities, persons of any sexual orientation or gender identity, and others who may contribute to the further diversification of ideas. Canadians and permanent residents of Canada will be given priority.